Publikationen von Udo Reichl

Dogra, T.; Pelz, L.; Marc, H.; Rüdiger, D.; Boehme, J.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Göbel, S.; Dorn, M.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)

Göbel, S.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Göbel, S.; Kortum, F.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)

Hein, M.; Chawla, A.; Arora , P.; Cattaneo, M.; Winkler, M.; Pöhlmann, S.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivation. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Hellwig, P.; Dittrich, A.; Benndorf, D.; Reichl, U.: Establishment of a click chemistry-based method for detection and characterizationof phage-host systems in anaerobic digestion. 2nd German Phage Symposium, Stuttgart, Germany (2022)

Hellwig, P.; Heyer, R.; Maus, I.; Meinusch, N.; Walke, D.; Schlüter, A.; Hassa, J.; Sczyrba, A.; Klocke, M.; Mächtig, T. et al.; Schallert, K.; Seick, I.; Saake, G.; Reichl, U.; Benndorf, D.: Combined metagenomics and metaproteomics for analysis of the microbial community in a two-stage biogas plant. XIV Annual Congress of the European Proteomic Association, Leipzig, Germany (2022)

Hoang Son, T.; Lange, F.; Mahour, R.; Rexer, T.; Reichl, U.: In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 32nd Joint Glycobiology Meeting, Utrecht, The Netherlands (2022)

Hoang Son, T.; Mahour, R.; Rexer, T.; Reichl, U.: In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 10th International Congress on Biocatalysis (Biocat2022), Hamburg, Germany (2022)

Khesali Aghtaei, H.; Benndorf, D.; Reichl, U.: Power to gas: Impact of changes in H₂ supply on performance and microbial community composition of a biological methanation process. Himmelfahrtstagung on Bioprocess Engineering 2022 - Future Bioprocesses for a Sustainable Industry (DECHEMA), Mainz, Germany (2022)

Khesali Aghtaei, H.; Benndorf, D.; Reichl, U.: Development of a tubular foam bioreactor for biological methanation. 8th International Conference on Renewable Energy Gas Technology (REGATEC 2022), Malmö, Sweden (2022)

Küchler, J.; Püttker, S.; Lahmann, P.; Genzel, Y.; Kupke, S. Y.; Benndorf, D.; Reichl, U.: Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Proteomic Forum 2022, Leipzig (Germany) (2022)

Kupke, S. Y.; Hein, M.D.; Bdeir, N.; Rand, U.; Marichal-Gallardo, P.; Cicin-Sain, L.; Bruder, D.; Pöhlmann, S.; Schughart, K.; Reichl, U.: Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. 31st Annual Meeting of the Society for Virology, online (2022)

Kupke, S. Y.; Hein, M.; Bdeir, N.; Rand, U.; Marichal-Gallardo, P.; Cicin-Sain, L.; Bruder, D.; Pöhlmann, S.; Schughart, K.; Reichl, U.: Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. Vaccine Technology VIII, Sitges (Spain) (2022)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F.G.; Genzel, Y.; Brooke, C.B.; Kupke, S. Y.; Reichl, U.: Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Wenzel, L.; Ruhnau, J.; Rexer, T.; Reichl, U.: Synthesis of synthetic lipid-linked oligosaccharides for the in-vitro glycoengineering of peptides. 15th Bratislava Symposium on Saccharides (15BSS), Smolenice (Slovakia) (2022)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Thiele, K.; Genzel, Y.; Reichl, U.: Generation and screening of monoclonal suspension MDCK cells for high-yield influenza A virus production. 3rd ESACT Frontiers Retreat, Vienna, Austria (2022)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Zinnecker, T. M.; Behrendt, I.; Lau, M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Suspension MDCK cell line development by automated single-cell cloning & scale-down into ambr^®15 microbioreactors in chemically defined medium. 27th ESACT Meeting, Lisbon (Portugal) (2022)